---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-006594"
form_type: "8-K"
ticker: "HRMY"
cik: "0001802665"
company_name: "Harmony Biosciences Holdings, Inc."
filed_at: "2024-05-03T23:59:59+00:00"
generated_at: "2026-06-02T23:16:20.010313+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Kumar Budur promoted to EVP and Chief Medical & Scientific Officer at Harmony Biosciences

## Summary
- Appointed EVP & Chief Medical & Scientific Officer effective May 1, 2024.
- Annual salary raised from $500,000 to $575,000; target bonus remains 50% of salary.
- Receives 75,000 RSUs and 75,000 stock options vesting over four years.
- Dr. Budur had been Chief Medical Officer; biography previously disclosed in proxy.

## SEC filing metadata
- accession: 0001558370-24-006594
- form_type: 8-K
- ticker: HRMY
- cik: 0001802665
- company_name: Harmony Biosciences Holdings, Inc.
- filed_at: 2024-05-03T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1802665/000155837024006594/0001558370-24-006594-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1802665/000155837024006594/hrmy-20240501x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-006594
- JSON: https://secwatch.observer/filing/0001558370-24-006594.json
- Plain text: https://secwatch.observer/filing/0001558370-24-006594.txt

## Key facts
- Executive change
  Kumar Budur was appointed as Executive Vice President and Chief Medical & Scientific Officer at Harmony Biosciences Holdings, Inc..
  - Action: appointed
  - Role: Executive Vice President and Chief Medical & Scientific Officer
  source text: appointed Kumar Budur, M.D., M.S., the Company’s Chief Medical Officer, to the title of Executive Vice President and Chief Medical & Scientific Officer (the “Appointment”), effective on May 1, 2024
  evidence_url: https://www.sec.gov/Archives/edgar/data/1802665/000155837024006594/0001558370-24-006594-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.